Point72 Hong Kong LTD Novavax Inc Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $24,684 - $52,564	-204 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $23,725 - $67,185	-210 Reduced 50.72%	204 $37,000
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $42,125 - $74,632	-535 Reduced 56.38%	414 $46,000
Q3 2020 Nov 16, 2020	SELL	$79.44 - $178.51 $14,299 - $32,131	-180 Reduced 15.94%	949 $103,000
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $15,647 - $94,395	1,129 New	1,129 $94,000

286

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $713M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.